| Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis F Ceban, S Ling, LMW Lui, Y Lee, H Gill, KM Teopiz, NB Rodrigues, ... Brain, behavior, and immunity 101, 93-135, 2022 | 1029 | 2022 |
| Stress, epigenetics and depression: a systematic review C Park, JD Rosenblat, E Brietzke, Z Pan, Y Lee, B Cao, H Zuckerman, ... Neuroscience & Biobehavioral Reviews 102, 139-152, 2019 | 394 | 2019 |
| Government response moderates the mental health impact of COVID-19: a systematic review and meta-analysis of depression outcomes across countries Y Lee, LMW Lui, D Chen-Li, Y Liao, RB Mansur, E Brietzke, JD Rosenblat, ... Journal of affective disorders 290, 364-377, 2021 | 204 | 2021 |
| Association between mood disorders and risk of COVID-19 infection, hospitalization, and death: a systematic review and meta-analysis F Ceban, D Nogo, IP Carvalho, Y Lee, F Nasri, J Xiong, LMW Lui, ... JAMA psychiatry 78 (10), 1079-1091, 2021 | 190 | 2021 |
| Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review B Cao, J Zhu, H Zuckerman, JD Rosenblat, E Brietzke, Z Pan, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 92, 109-117, 2019 | 135 | 2019 |
| Impact of SARS-CoV-2 infection on cognitive function: a systematic review Y Alnefeesi, A Siegel, LMW Lui, KM Teopiz, RCM Ho, Y Lee, F Nasri, ... Frontiers in Psychiatry 11, 621773, 2021 | 109 | 2021 |
| Vitamin D and Graves’ disease: a meta-analysis update MY Xu, B Cao, J Yin, DF Wang, KL Chen, QB Lu Nutrients 7 (5), 3813-3827, 2015 | 107 | 2015 |
| The neural systems of emotion regulation and abnormalities in major depressive disorder C Park, JD Rosenblat, Y Lee, Z Pan, B Cao, M Iacobucci, RS McIntyre Behavioural brain research 367, 181-188, 2019 | 105 | 2019 |
| Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis Y Alnefeesi, D Chen-Li, E Krane, MY Jawad, NB Rodrigues, F Ceban, ... Journal of psychiatric research 151, 693-709, 2022 | 99 | 2022 |
| Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta‐analysis B Cao, JD Rosenblat, E Brietzke, C Park, Y Lee, N Musial, Z Pan, ... Diabetes, Obesity and Metabolism 20 (10), 2467-2471, 2018 | 96 | 2018 |
| The efficacy of vortioxetine on anhedonia in patients with major depressive disorder B Cao, C Park, M Subramaniapillai, Y Lee, M Iacobucci, RB Mansur, ... Frontiers in psychiatry 10, 17, 2019 | 91 | 2019 |
| Soluble TREM2 changes during the clinical course of Alzheimer’s disease: A meta-analysis D Liu, B Cao, Y Zhao, H Huang, RS McIntyre, JD Rosenblat, H Zhou Neuroscience letters 686, 10-16, 2018 | 84 | 2018 |
| Leptin and adiponectin levels in major depressive disorder: a systematic review and meta-analysis B Cao, Y Chen, E Brietzke, D Cha, A Shaukat, Z Pan, C Park, ... Journal of affective disorders 238, 101-110, 2018 | 69 | 2018 |
| Association of anaemia with Helicobacter pylori infection: a retrospective study MY Xu, B Cao, BS Yuan, J Yin, L Liu, QB Lu Scientific reports 7 (1), 13434, 2017 | 69 | 2017 |
| Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research F Ceban, A Leber, MY Jawad, M Yu, LMW Lui, M Subramaniapillai, ... Infectious Diseases 54 (7), 467-477, 2022 | 60 | 2022 |
| Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre-and post-treatment study B Cao, D Wang, Z Pan, E Brietzke, RS McIntyre, N Musial, RB Mansur, ... Translational psychiatry 9 (1), 19, 2019 | 55 | 2019 |
| The utility of smartphone-based, ecological momentary assessment for depressive symptoms SJ Yim, LMW Lui, Y Lee, JD Rosenblat, RM Ragguett, C Park, ... Journal of Affective Disorders 274, 602-609, 2020 | 54 | 2020 |
| Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia D Wang, SL Cheng, Q Fei, H Gu, D Raftery, B Cao, X Sun, J Yan, C Zhang, ... Psychiatry research 272, 18-29, 2019 | 53 | 2019 |
| Prevention and management of common adverse effects of ketamine and esketamine in patients with mood disorders F Ceban, JD Rosenblat, K Kratiuk, Y Lee, NB Rodrigues, H Gill, ... CNS drugs 35 (9), 925-934, 2021 | 48 | 2021 |
| Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: a systematic review and meta-analysis YK Liu, S Ling, LMW Lui, F Ceban, M Vinberg, LV Kessing, RC Ho, ... Journal of affective disorders 300, 449-461, 2022 | 47 | 2022 |
Joshua RosenblatUniversity of Toronto在 utoronto.ca 的电子邮件经过验证
